Immunic, Inc.(IMUX)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
IMUX is scheduled to report on Nov 11, 2026, before the market opens. Analysts expect EPS of -$0.96.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±6.6%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 7 misses.
In plain words: it beat expectations 5 times, but the stock still fell 2 of those 5 times.
- Aug '26Beat▲ +9.8%
- May '26Missed▲ +8.8%
- Feb '26Beat▲ +4.2%
- Nov '25Beat▼ -6.2%
- Aug '25Missed▼ -7.9%
- May '25Missed▼ -3.5%
- Mar '25Missed▼ -9.2%
- Nov '24Missed▼ 0.0%
- Aug '24Beat▲ +14.5%
- May '24Missed▼ -8.0%
- Feb '24Beat▼ -4.7%
- Nov '23Missed▲ +2.2%
Clear beats and misses with a known reaction only. What counts as a beat
Why did IMUX fall after beating earnings?
4 of IMUX's last 12 reactions went against the EPS result. What stands out in each:
IMUX beat EPS estimates in 5 quarters, and the stock still closed lower the next day 2 times.
- Nov 13, 2025EPS beat +26.6%stock -6.2% next day
- It had risen 5.1% in the final week before the report, so good news may already have been priced in.
- It opened 2.6% higher, but sellers took over and it closed -6.2%.
- Feb 22, 2024EPS beat +11.1%stock -4.7% next day
- It had risen 12.3% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 1.6% higher, but sellers took over and it closed -4.7%.
Rose despite an EPS miss (2 of 7)
- May 13, 2026EPS missed -12.5%stock +8.8% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 14, 2023EPS missed -0.6%stock +2.2% next day
- It had already fallen 21.2% in the 20 trading sessions before the report, so weak results may have been expected.
- The EPS miss was small (-0.6%).
- It opened 4.2% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was IMUX's earnings move already priced in?
IMUX's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does IMUX hold its opening gap after earnings?
IMUX's opening move after each report and where it closed that day.
In 8 reports IMUX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 4 times. Gaps up faded 2 of 4; gaps down recovered 2 of 4.
- May 13, 2026ReversedOpened -3.3%, closed +8.8%
- Feb 26, 2026HeldOpened +1.5%, closed +4.2%
- Nov 13, 2025ReversedOpened +2.6%, closed -6.2%
- Mar 31, 2025HeldOpened -1.7%, closed -9.2%
- Aug 8, 2024ReversedOpened -6.0%, closed +14.5%
- May 8, 2024HeldOpened -2.9%, closed -8.0%
- Feb 22, 2024ReversedOpened +1.6%, closed -4.7%
- Nov 14, 2023HeldOpened +4.2%, closed +2.2%
What the history says
- It fell after 2 of its 5 EPS beats (40%): beating estimates has not been enough on its own.
IMUX earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Before open | -$1.16 | -$0.80 | +31.0% | +9.79% | +17.59% |
| May 13, 2026 | Before open | -$0.96 | -$1.08 | -12.5% | +8.82% | +1.51% |
| Feb 26, 2026 | Before open | -$1.11 | -$0.70 | +36.9% | +4.18% | +16.48% |
| Nov 13, 2025 | Before open | -$1.77 | -$1.30 | +26.6% | -6.18% | -3.95% |
| Aug 7, 2025 | Before open | -$1.58 | -$2.00 | -26.6% | -7.87% | -13.28% |
| May 15, 2025 | After close | -$2.40 | -$2.50 | -4.2% | -3.51% | -2.21% |
| Mar 31, 2025 | Before open | -$2.38 | -$2.50 | -5.0% | -9.17% | -7.50% |
| Nov 7, 2024 | Before open | -$2.18 | -$2.40 | -10.1% | 0.00% | +4.24% |
| Aug 8, 2024 | Before open | -$2.33 | -$2.10 | +9.9% | +14.53% | +13.68% |
| May 8, 2024 | Before open | -$2.65 | -$3.00 | -13.2% | -7.97% | -7.97% |
| Feb 22, 2024 | Before open | -$5.40 | -$4.80 | +11.1% | -4.69% | 0.00% |
| Nov 14, 2023 | Before open | -$5.07 | -$5.10 | -0.6% | +2.17% | +6.30% |
Consensus for the next report: EPS -$0.96, revenue $0.00.
IMUX Earnings FAQ
Answers computed from Immunic, Inc.'s reported history
IMUX is scheduled to report on Nov 11, 2026, before the market opens. Analysts expect EPS of -$0.96.
Over the last 12 quarters with a usable EPS surprise, IMUX beat the consensus estimate 5 times (42%), missed 7 and landed in line 0.
Across its last 12 quarters with a measured reaction, IMUX moved an average of ±6.6% in the first session after reporting. It closed higher 42% of the time; the largest gain was 14.5% and the largest drop -9.2%.
IMUX fell in the first session after 2 of its last 5 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 12 quarters with price data, IMUX moved an average of +2.5% in the 20 trading sessions before reporting and was higher in 58% of them. After a run-up of 3% or more (5 quarters), it fell the next day 80% of the time, averaging -4.0%. After a drop of 3% or more (5 quarters), it rose the next day 60% of the time, averaging +4.1%. This describes past reports; it is not a forecast.
In 8 reports IMUX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · IMUX: 12 reported quarters, latest Aug 11, 2026. Information only, not investment advice.
Looking for more on IMUX?
Price charts, forecast, fundamentals and risk pages for IMUX are not on Tickzen yet. You can run a full stock analysis now.
Run the IMUX Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun